BioXcel Therapeutics is a biopharmaceutical company that focuses on artificial intelligence for neuroscience. It offers an orally dissolving sublingual film formulation of dexmedetomidine in the treatment of psychiatric and neurological disorders, as well as a sublingual film for the acute treatment of schizophrenia or bipolar disorders, etc. The company also provides an AI platform for drug development.